Stephen A. Sherwin, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 15,000 shares at $74.43 ($1.1M) on 2022-01-24, disclosed to the SEC on 2022-01-26.
Open-market sale of $1.1M NBIX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2025-02-14 | $3.2M | — | Filing → |
| NBIX | SELL | 2024-05-30 | $5.3M | — | Filing → |
| NBIX | SELL | 2023-01-05 | $3.6M | — | Filing → |